To study the effect of placing a stent versus no stent on complications and bile duct stone recurrence rate after clearance in those awaiting gall bladder removal operatio
Not Applicable
- Conditions
- Health Condition 1: K807- Calculus of gallbladder and bile duct without cholecystitis
- Registration Number
- CTRI/2024/03/063685
- Lead Sponsor
- PGIMER
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Cases of cholelithiasis with concomitant choledocholithiasis in whom CBD clearance is achieved will be included
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the biliary and pancreatic complications in the form of cholangitis, cholecystitis, biliary pancreatitis and post ERC pancreatitis between the stent and the no stent groupsTimepoint: From ERC and clearance of stone in ERC till the time period of 3 months irrespective of the timing of cholecystectomy.
- Secondary Outcome Measures
Name Time Method - To compare the CDL recurrence rate between the stent and the no stent groups <br/ ><br>-To compare the need for repeat ERC between the stent and the no stent groupsTimepoint: From ERC and clearance of stone in ERC till the time period of 3 months irrespective of the timing of
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie prophylactic biliary stent efficacy in preventing choledocholithiasis recurrence post-clearance?
How does CTRI/2024/03/063685 STONE trial compare stent placement to standard endoscopic clearance in reducing biliary complications?
Are there predictive biomarkers for response to prophylactic biliary stents in K807 patients awaiting cholecystectomy?
What adverse events are associated with prophylactic biliary stents versus no stent in choledocholithiasis management?
What combination therapies or devices synergize with biliary stents to improve stone recurrence prevention in gallbladder disease?